115 related articles for article (PubMed ID: 25534904)
1. Iron(III)-binding of the anticancer agents doxorubicin and vosaroxin.
Mjos KD; Cawthray JF; Jamieson G; Fox JA; Orvig C
Dalton Trans; 2015 Feb; 44(5):2348-58. PubMed ID: 25534904
[TBL] [Abstract][Full Text] [Related]
2. Host-guest interactions in Fe(III)-trimesate MOF nanoparticles loaded with doxorubicin.
Anand R; Borghi F; Manoli F; Manet I; Agostoni V; Reschiglian P; Gref R; Monti S
J Phys Chem B; 2014 Jul; 118(29):8532-9. PubMed ID: 24960194
[TBL] [Abstract][Full Text] [Related]
3. Molecular and Pharmacologic Properties of the Anticancer Quinolone Derivative Vosaroxin: A New Therapeutic Agent for Acute Myeloid Leukemia.
Jamieson GC; Fox JA; Poi M; Strickland SA
Drugs; 2016 Sep; 76(13):1245-1255. PubMed ID: 27484675
[TBL] [Abstract][Full Text] [Related]
4. Preclinical characterization of anticancer gallium(III) complexes: solubility, stability, lipophilicity and binding to serum proteins.
Rudnev AV; Foteeva LS; Kowol C; Berger R; Jakupec MA; Arion VB; Timerbaev AR; Keppler BK
J Inorg Biochem; 2006 Nov; 100(11):1819-26. PubMed ID: 16938349
[TBL] [Abstract][Full Text] [Related]
5. Stability and iron coordination in DNA adducts of Anthracycline based anti-cancer drugs.
Eizaguirre A; Yáñez M; Eriksson LA
Phys Chem Chem Phys; 2012 Sep; 14(36):12505-14. PubMed ID: 22699973
[TBL] [Abstract][Full Text] [Related]
6. Gallium Complexes as Anticancer Drugs.
Chitambar CR
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394029
[TBL] [Abstract][Full Text] [Related]
7. Gallium(iii) and iron(iii) complexes of quinolone antimicrobials.
Mjos KD; Cawthray JF; Polishchuk E; Abrams MJ; Orvig C
Dalton Trans; 2016 Aug; 45(33):13146-60. PubMed ID: 27315225
[TBL] [Abstract][Full Text] [Related]
8. Gallium(III) and iron(III) complexes of alpha-N-heterocyclic thiosemicarbazones: synthesis, characterization, cytotoxicity, and interaction with ribonucleotide reductase.
Kowol CR; Berger R; Eichinger R; Roller A; Jakupec MA; Schmidt PP; Arion VB; Keppler BK
J Med Chem; 2007 Mar; 50(6):1254-65. PubMed ID: 17315858
[TBL] [Abstract][Full Text] [Related]
9. Vosaroxin : a novel antineoplastic quinolone.
Abbas JA; Stuart RK
Expert Opin Investig Drugs; 2012 Aug; 21(8):1223-33. PubMed ID: 22724917
[TBL] [Abstract][Full Text] [Related]
10. Observation of redox-induced electron transfer and spin crossover for dinuclear cobalt and iron complexes with the 2,5-di-tert-butyl-3,6-dihydroxy-1,4-benzoquinonate bridging ligand.
Min KS; Dipasquale AG; Rheingold AL; White HS; Miller JS
J Am Chem Soc; 2009 May; 131(17):6229-36. PubMed ID: 19358538
[TBL] [Abstract][Full Text] [Related]
11. Novel iron(III) complexes of sterically hindered 4N ligands: regioselectivity in biomimetic extradiol cleavage of catechols.
Mayilmurugan R; Stoeckli-Evans H; Palaniandavar M
Inorg Chem; 2008 Aug; 47(15):6645-58. PubMed ID: 18597419
[TBL] [Abstract][Full Text] [Related]
12. Solution structure of iron(III)-anthracycline complexes.
Fiallo MM; Drechsel H; Garnier-Suillerot A; Matzanke BF; Kozlowski H
J Med Chem; 1999 Jul; 42(15):2844-51. PubMed ID: 10425093
[TBL] [Abstract][Full Text] [Related]
13. Production of hydroxyl radical by iron(III)-anthraquinone complexes through self-reduction and through reductive activation by the xanthine oxidase/hypoxanthine system.
Malisza KL; Hasinoff BB
Arch Biochem Biophys; 1995 Aug; 321(1):51-60. PubMed ID: 7639535
[TBL] [Abstract][Full Text] [Related]
14. Vosaroxin: a new valuable tool with the potential to replace anthracyclines in the treatment of AML?
Freeman C; Keane N; Swords R; Giles F
Expert Opin Pharmacother; 2013 Jul; 14(10):1417-27. PubMed ID: 23688047
[TBL] [Abstract][Full Text] [Related]
15. Structural and electronic behavior of unprecedented five-coordinate iron(III) and gallium(III) complexes with a new phenol-rich electroactive ligand.
Lanznaster M; Hratchian HP; Heeg MJ; Hryhorczuk LM; McGarvey BR; Schlegel HB; Verani CN
Inorg Chem; 2006 Feb; 45(3):955-7. PubMed ID: 16441098
[TBL] [Abstract][Full Text] [Related]
16. Structural study of Ga(III), In(III), and Fe(III) complexes of triaza-macrocycle based ligands with N3S3 donor set.
Notni J; Pohle K; Peters JA; Görls H; Platas-Iglesias C
Inorg Chem; 2009 Apr; 48(7):3257-67. PubMed ID: 19281197
[TBL] [Abstract][Full Text] [Related]
17. Interaction of Triapine and related thiosemicarbazones with iron(III)/(II) and gallium(III): a comparative solution equilibrium study.
Enyedy ÉA; Primik MF; Kowol CR; Arion VB; Kiss T; Keppler BK
Dalton Trans; 2011 Jun; 40(22):5895-905. PubMed ID: 21523301
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of Fe(III) and Pb(ll) complexes with 3-hydroxypyridine-2(1H)-thiones.
Katoh A; Harada K; Saito R
Hemoglobin; 2006; 30(1):81-92. PubMed ID: 16540420
[TBL] [Abstract][Full Text] [Related]
19. Secondary alcohol metabolites mediate iron delocalization in cytosolic fractions of myocardial biopsies exposed to anticancer anthracyclines. Novel linkage between anthracycline metabolism and iron-induced cardiotoxicity.
Minotti G; Cavaliere AF; Mordente A; Rossi M; Schiavello R; Zamparelli R; Possati G
J Clin Invest; 1995 Apr; 95(4):1595-605. PubMed ID: 7706466
[TBL] [Abstract][Full Text] [Related]
20. Interactions of iron-anthracycline complexes with living cells: a microspectrofluorometric study.
Fiallo M; Laigle A; Garnier-Suillerot A; Amirand C; Ballini JP; Chinsky L; Duquesne M; Jolles B; Sureau F; Turpin PY
Biochim Biophys Acta; 1993 Jun; 1177(3):236-44. PubMed ID: 8323977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
